SOLID TUMOR MALIGNANCIES
Clinical trials for SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug ZE94-0605 enters first human tests
Disease control Not yet recruitingThis early-phase study tests an experimental drug called ZE94-0605 in about 60 adults with advanced solid tumors (like lung, ovarian, or other cancers) that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers w…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
Could a common fruit acid boost cancer immunotherapy?
Disease control Not yet recruitingThis early-phase study tests whether adding malic acid (a natural fruit acid) to standard immunotherapy is safe and helps control tumors in people with solid cancers like colorectal, lung, or melanoma. About 30 adults currently on immunotherapy will take oral malic acid. Research…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
New pill shows promise against Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests an experimental drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check if the drug can shrink tumors. About 219 adults will take part in this early-phase trial.
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Custom mRNA vaccine takes on Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a personalized mRNA vaccine (RH125) in 36 adults with advanced solid tumors that have not responded to standard treatments. The vaccine is designed to train the immune system to attack each patient's unique cancer. Researchers will check safety, immun…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Hearing shield: new drug may prevent Chemo-Induced hearing loss in adults
Symptom relief Not yet recruitingThis study tests whether a drug called Pedmark (sodium thiosulfate) can reduce hearing loss in adults receiving cisplatin chemotherapy for cancers like testicular, head and neck, or thoracic cancer. About 25 adults will receive Pedmark alongside their standard chemo to see if it …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC
-
Cancer Patients' mental health: scientists hunt for biomarkers
Knowledge-focused Not yet recruitingThis study aims to find biological markers (proteins from tumors) linked to anxiety and depression in people with solid tumors. Researchers will collect tumor tissue and blood samples from 100 adult patients and combine that with psychological assessments. The goal is to better u…
Matched conditions: SOLID TUMOR MALIGNANCIES
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
New study aims to predict dangerous side effects of cancer immunotherapy before they happen
Knowledge-focused Not yet recruitingThis study will look at 160 adults with solid tumors who are about to start immunotherapy. Researchers will collect blood, stool, and imaging data to find patterns that could predict which patients will have severe side effects. The goal is to create a test that helps doctors pre…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC